Francine Kaufman - Feb 10, 2022 Form 4 Insider Report for Senseonics Holdings, Inc. (SENS)

Role
Chief Medical Officer, Director
Signature
/s/ Darren K. DeStefano, Attorney-in-Fact
Stock symbol
SENS
Transactions as of
Feb 10, 2022
Transactions value $
-$403,120
Form type
4
Date filed
2/14/2022, 06:47 PM
Previous filing
Nov 18, 2021
Next filing
May 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SENS Common Stock Award $0 +311K +28.92% $0.00 1.39M Feb 10, 2022 Direct F1
transaction SENS Common Stock Sale -$403K -164K -11.82% $2.46 1.22M Feb 11, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a performance-based restricted stock unit ("RSU") award, which represent a contingent right to receive one share of the Issuer's common stock and vest upon the achievement of certain performance targets, subject to the Reporting Person's continuous service through the vesting events. 100% of the RSUs vested on February 10, 2022 upon the achievement of the performance vesting criteria.
F2 Represents shares sold to cover tax obligations upon the vesting of RSUs.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.575 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.